Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China [Phase 4]
Phase 4 clinical trial investigating montelukast for accelerated atherosclerosis related to air pollution (PM2.5) in China.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI [Phase 4]
Phase 4 trial evaluating an inflammasome inhibitor's effect on hsCRP levels after PCI.
-
FDA approval · 2023-02-02FDA Approved: REGADENOSON — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc. for Regadenoson (ANDA 215827) as a generic injectable pharmacologic stress agent for myocardial …
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery [Phase 4]
Phase 4 trial update studying topical tranexamic acid to reduce postoperative bleeding and blood product transfusion after cardiac surgery i…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Chewed Versus Integral Pill of Ticagrelor [Phase 4]
Phase 4 clinical trial comparing chewed versus intact ticagrelor tablets in patients undergoing percutaneous coronary intervention; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: 3D PET Myocardial Blood Flow and Rb82 Infusion Profiles [Phase 4]
Phase 4 trial update evaluating 3D PET myocardial blood flow and Rb82 infusion profiles in normal healthy volunteers and individuals with co…
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG
A completed clinical trial assessing myocardial ischemic-reperfusion injury in off- and on-pump CABG procedures; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Improving Adherence to Medication After Coronary Artery Bypass Surgery (CABG) in Older Adults [Phase 2]
A Phase 2 clinical trial updating strategies to improve medication adherence after coronary artery bypass grafting in older adults has compl…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Ferumoxytol-enhanced Magnetic Resonance Imaging [Phase 3]
Phase 3 clinical trial update for ferumoxytol-enhanced MRI in coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS) [Phase 4]
Phase 4 trial evaluating rivaroxaban estimation with warfarin in atrial fibrillation patients with coronary stent implantation (REWRAPS).
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Regadenoson Real Time Perfusion Imaging Trial-Optison [Phase 3]
Phase 3 trial evaluating regadenoson real-time perfusion imaging with Optison has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV) [NA]
Clinical trial update on the safety and effectiveness of a paclitaxel-coated PTCA balloon catheter for coronary artery disease. The study is…
-
FDA approval · 2022-12-16FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for the fixed-dose combination of ezetimibe and simvastatin from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study [Phase 4]
Phase 4 randomized study comparing ticagrelor versus prasugrel on coronary microcirculation in patients undergoing elective PCI (PROMICRO-3)…
-
FDA approval · 2022-12-06FDA Approved: MYOVIEW — Supplemental Application (Medi-Physics Inc. dba GE Healthcare)
FDA approved a supplemental application for MYOVIEW (tetrofosmin) submitted by Medi-Physics Inc. dba GE Healthcare.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease [Phase 4]
A Phase 4 clinical trial comparing LDL cholesterol-targeting statin therapy to intensity-based statin therapy in patients with coronary arte…
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). [Phase 4]
A Phase 4 trial update on de-prescribing beta blockers after coronary artery bypass graft surgery, investigating safety/efficacy implication…
-
FDA approval · 2022-11-07FDA Approved: ISOSORBIDE MONONITRATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for Isosorbide Mononitrate from Aurobindo Pharma Limited.
-
FDA approval · 2022-11-03FDA Approved: AMMONIA N 13 — Original Application (University of Alabama at Birmingham)
FDA approved the original application for Ammonia N-13 (NH3N13), a radiopharmaceutical imaging agent developed by the University of Alabama …
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: The POST-ACS Study [Phase 4]
A Phase 4 clinical trial update for the POST-ACS study, involving patients with diabetes mellitus and acute coronary syndrome, with status c…
-
FDA approval · 2022-10-26FDA Approved: REGADENOSON — Original Application (Eugia US LLC)
FDA approved Regadenoson via an original application for Eugia US LLC (ANDA216437), enabling a generic version of Regadenoson for pharmacolo…
-
CLINICAL_TRIALS research · 2022-10-12Clinical Trial Update: Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI) [Phase 4]
Phase 4 trial evaluating optimization of enoxaparin dosing during PCI to improve anticoagulation management.
-
CLINICAL_TRIALS trial_result · 2022-09-30Clinical Trial Update: Ketorolac-an Option for Post Operative Pain Management After Elective Cardiac Surgery. [Phase 4]
A Phase 4 trial evaluating ketorolac as an option for post-operative pain management after elective cardiac surgery has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease [Phase 4]
Phase 4 trial update on dapagliflozin therapy effects for myocardial perfusion reserve in prediabetic patients with stable coronary artery d…
-
CLINICAL_TRIALS withdrawal · 2022-09-22Clinical Trial Update: Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization [Phase 3]
Phase 3 trial of adipose stromal cell injection in the myocardium for revascularization was withdrawn.